A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas

被引:267
|
作者
Crowe, NY
Smyth, MJ
Godfrey, DI
机构
[1] Monash Univ, Sch Med, Dept Pathol & Immunol, Prahran, Vic 3181, Australia
[2] Peter MacCallum Canc Inst, Trescowthick Labs, Melbourne, Vic 3002, Australia
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 2002年 / 196卷 / 01期
关键词
rodent; NKT cells; NK cells; tumor immunity; methylcholanthrene;
D O I
10.1084/jem.20020092
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural killer (NK) T cells initiate potent antitumor responses when stimulated by exogenous factors such as interleukin (IL)-12 or alpha-galactosylceramide (alpha-GalCer), however, it is not clear whether this reflects a physiological role for these cells in tumor immunity. Through adoptive transfer of NK T cells from wild-type to NK T cell-deficient (T cell receptor [TCR] Jalpha281(-/-)) mice, we demonstrate a critical role for NK T cells in immunosurveillance of methylcholanthrene (MCA)-induced fibrosarcomas, in the absence of exogenous stimulatory factors. Using the same approach with gene-targeted and/or antibody-depleted donor or recipient mice, we have shown that this effect depends on CD1d recognition and requires the additional involvement of both NK and CD8(+) T cells. Interferon-gamma production by both NK T cells and downstream, non-NK T cells, is essential for protection, and perform production by effector cells, but not NK T cells, is also critical. The protective mechanisms in this more physiologically relevant system are distinct from those associated with alpha-GalCer-induced, NK T cell-mediated, tumor rejection. This study demonstrates that, in addition to their importance in tumor immunotherapy induced by IL-12 or alpha-GalCer, NK T cells can play a critical role in tumor immunosurveillance, at least against MCA-induced sarcomas, in the absence of exogenous stimulation.
引用
收藏
页码:119 / 127
页数:9
相关论文
共 50 条
  • [1] IMMUNITY TO METHYLCHOLANTHRENE-INDUCED SARCOMAS
    PREHN, RT
    MAIN, JM
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1957, 18 (06) : 769 - 778
  • [2] SPLENIC RESPONSE TO METHYLCHOLANTHRENE-INDUCED SARCOMAS
    MING, SC
    MING, PML
    AMERICAN JOURNAL OF PATHOLOGY, 1969, 55 (03): : A8 - &
  • [3] NEUTRALIZING EFFECT OF SPLEEN CELLS ON TRANSPLANTED METHYLCHOLANTHRENE-INDUCED SARCOMAS
    MING, SC
    MING, PML
    AMERICAN JOURNAL OF PATHOLOGY, 1970, 59 (03): : A90 - &
  • [4] PROPERTIES OF TRANSPLANTABLE METHYLCHOLANTHRENE-INDUCED SARCOMAS IN THE NEWT
    BREEDIS, C
    AMERICAN JOURNAL OF PATHOLOGY, 1952, 28 (03): : 560 - 560
  • [5] HUMORAL ANTIBODIES AGAINST METHYLCHOLANTHRENE-INDUCED SARCOMAS
    LEZHNEVA, OM
    IEVLEVA, ES
    ZILBER, LA
    DOKLADY AKADEMII NAUK SSSR, 1965, 162 (06): : 1440 - &
  • [6] CITATION CLASSIC - IMMUNITY TO METHYLCHOLANTHRENE-INDUCED SARCOMAS
    PREHN, RT
    CURRENT CONTENTS/LIFE SCIENCES, 1985, (15): : 21 - 21
  • [7] Identification and editing of stem-like cells in methylcholanthrene-induced sarcomas
    Gross, Emilie T. E.
    Peinado, Carlos D.
    Jung, Yujin
    Han, Semi
    Liu, Beichen
    Santosa, Endi K.
    Bui, Jack D.
    ONCOIMMUNOLOGY, 2019, 8 (01):
  • [8] FAILURE OF NATURAL-KILLER CELLS IN SUPPRESSION OF METHYLCHOLANTHRENE-INDUCED PRIMARY TUMORS IN SHR WITH T-CELL DEFICIENCY
    TAKEICHI, N
    BA, D
    KOGA, Y
    KOBAYASHI, H
    JAPANESE HEART JOURNAL, 1983, 24 (05): : 835 - 835
  • [9] NON-T SUPPRESSOR CELLS IN THE LYMPH-NODES OF MICE BEARING METHYLCHOLANTHRENE-INDUCED SARCOMAS
    INDROVA, M
    BUBENIK, J
    FOLIA BIOLOGICA, 1981, 27 (03) : 217 - 222
  • [10] TUMOR AUTOIMMUNITY AGAINST METHYLCHOLANTHRENE-INDUCED SARCOMAS OF RAT
    TAKEDA, K
    AIZAWA, M
    KIKUCHI, Y
    YAMAWAKI, SY
    NAKAMURA, K
    GANN, 1966, 57 (03): : 221 - &